Cooper, M; Metz, J; de Wit, H et al. (1998) Interclass drug effects and changes in regional brain glucose metabolism. Psychopharmacol Bull 34:229-32
|
Cook Jr, E H; Stein, M A; Krasowski, M D et al. (1995) Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-8
|
Cook Jr, E H; Charak, D A; Arida, J et al. (1994) Depressive and obsessive-compulsive symptoms in hyperserotonemic parents of children with autistic disorder. Psychiatry Res 52:25-33
|
Cook Jr, E H; Metz, J; Leventhal, B L et al. (1994) Fluoxetine effects on cerebral glucose metabolism. Neuroreport 5:1745-8
|
Cook Jr, E H; Fletcher, K E; Wainwright, M et al. (1994) Primary structure of the human platelet serotonin 5-HT2A receptor: identify with frontal cortex serotonin 5-HT2A receptor. J Neurochem 63:465-9
|
Cook Jr, E H; Arora, R C; Anderson, G M et al. (1993) Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sci 52:2005-15
|
Cook Jr, E H; Anderson, G M; Heninger, G R et al. (1992) Tryptophan loading in hyperserotonemic and normoserotonemic adults. Biol Psychiatry 31:525-8
|
Cook Jr, E H; Metz, J; Cooper, M D et al. (1992) Fenfluramine and cerebral glucose. Biol Psychiatry 31:1173-4
|
Cook Jr, E H; Rowlett, R; Jaselskis, C et al. (1992) Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J Am Acad Child Adolesc Psychiatry 31:739-45
|
Jaselskis, C A; Cook Jr, E H; Fletcher, K E et al. (1992) Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin Psychopharmacol 12:322-7
|